BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9626883)

  • 21. MnDPDP as a negative hepatic contrast agent: evaluation of STIR imaging compared with T1-weighted SE and GE techniques.
    Halavaara JT; Lamminen AE
    J Comput Assist Tomogr; 1997; 21(1):94-9. PubMed ID: 9022776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: in vitro metabolism and protein binding studies of the active component MnDPDP in human blood.
    Toft KG; Kindberg GM; Skotland T
    J Pharm Biomed Anal; 1997 Apr; 15(7):983-8. PubMed ID: 9160265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An apparent unidirectional influx constant for manganese as a measure of myocardial calcium channel activity.
    Skjold A; Kristoffersen A; Vangberg TR; Haraldseth O; Jynge P; Larsson HB
    J Magn Reson Imaging; 2006 Nov; 24(5):1047-55. PubMed ID: 17024667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration.
    Hustvedt SO; Grant D; Southon TE; Zech K
    Acta Radiol; 1997 Jul; 38(4 Pt 2):690-9. PubMed ID: 9245964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue distribution and general safety of MnDPDP in male beagle dogs, with or without total common bile duct obstruction.
    Grant D; Toft KG; Martinsen I; Atzpodien E
    Acta Radiol; 1997 Jul; 38(4 Pt 2):732-9. PubMed ID: 9245969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manganese-calcium interactions with contrast media for cardiac magnetic resonance imaging: a study of manganese chloride supplemented with calcium gluconate in isolated Guinea pig hearts.
    Bruvold M; Nordhøy W; Anthonsen HW; Brurok H; Jynge P
    Invest Radiol; 2005 Mar; 40(3):117-25. PubMed ID: 15714086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue.
    Jynge P; Skjold AM; Falkmer U; Andersson RGG; Seland JG; Bruvold M; Blomlie V; Eidsaunet W; Karlsson JOG
    Contrast Media Mol Imaging; 2020; 2020():3262835. PubMed ID: 32994754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Mn-DPDP and manganese chloride on hemodynamics and glucose tolerance in anesthetized rats.
    Gao X; Sandberg M; Quach M; Bodin B; Johansson L; Jansson L
    Acta Radiol; 2014 Apr; 55(3):328-34. PubMed ID: 23963152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The need for effective contrast agents to enhance the performance of MR imaging.
    Grant D; Refsum H; Rummeny E; Marchal G
    Acta Radiol; 1997 Jul; 38(4 Pt 2):623-5. PubMed ID: 9245954
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiovascular safety of MnDPDP and MnCl2.
    Jynge P; Brurok H; Asplund A; Towart R; Refsum H; Karlsson JO
    Acta Radiol; 1997 Jul; 38(4 Pt 2):740-9. PubMed ID: 9245970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new opportunity for MEMRI.
    Cloyd R; Vandsburger M; Abisambra JF
    Aging (Albany NY); 2017 Aug; 9(8):1855-1856. PubMed ID: 28854148
    [No Abstract]   [Full Text] [Related]  

  • 33. Manganese dipyridoxyl diphosphate (MnDPDP)-enhanced magnetic resonance imaging of acute reperfused myocardial injury in a cat model: part II: comparison with cine magnetic resonance imaging.
    Yang DH; Kim TH; Choi JW; Kim ST; Yoon JH; Shin JH; Seo JB; Lim TH
    Invest Radiol; 2005 Jan; 40(1):56-61. PubMed ID: 15597021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The reproductive toxicology of intravenously administered MnDPDP in the rat and rabbit.
    Grant D; Blazak WF; Brown GL
    Acta Radiol; 1997 Jul; 38(4 Pt 2):759-69. PubMed ID: 9245972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implications of studies with MnDPDP in animal models of hepatic abnormalities.
    Ni Y; Marchal G
    Acta Radiol; 1997 Jul; 38(4 Pt 2):724-31. PubMed ID: 9245968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers.
    Wang C; Gordon PB; Hustvedt SO; Grant D; Sterud AT; Martinsen I; Ahlström H; Hemmingsson A
    Acta Radiol; 1997 Jul; 38(4 Pt 2):665-76. PubMed ID: 9245962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular effects of MnDPDP and MnCl2 in dogs with acute ischaemic heart failure.
    Karlsson JO; Mortensen E; Pedersen HK; Sager G; Refsum H
    Acta Radiol; 1997 Jul; 38(4 Pt 2):750-8. PubMed ID: 9245971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manganese toxicity upon overexposure.
    Crossgrove J; Zheng W
    NMR Biomed; 2004 Dec; 17(8):544-53. PubMed ID: 15617053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technical report: lymph node enhancement at MRI with MnDPDP in primary hepatic carcinoma.
    Burkill GJ; Mannion EM; Healy JC
    Clin Radiol; 2001 Jan; 56(1):67-71. PubMed ID: 11162701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mangafodipir (MnDPDP)-and MnCl2-induced endothelium-dependent relaxation in bovine mesenteric arteries.
    Asplund A; Grant D; Karlsson JO
    J Pharmacol Exp Ther; 1994 Nov; 271(2):609-14. PubMed ID: 7965775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.